5-HT3 receptor blockers
Smith, R.A.
Surgery 110(3): 575
1991
ISSN/ISBN: 0039-6060 PMID: 1653465 Document Number: 379101
Document emailed within 1 workday
Related Documents
Kimura, M.; Kimura, I.; Kondoh, T.; Tsuneki, H. 1991: Noncontractile acetylcholine receptor-operated Ca++ mobilization: suppression of activation by open channel blockers and acceleration of desensitization by closed channel blockers in mouse diaphragm muscle Journal of Pharmacology and Experimental Therapeutics 256(1): 18-23Aoyama, N. 2007: Effect of combination therapy with angiotensin Ii type i receptor and aldosterone receptor blockers in heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 145-149
Lommi, J. 2005: Angiotensin II-receptor blockers Duodecim; Laaketieteellinen Aikakauskirja 121(6): 589-592
Pavlotzky, M.; Eschchar, I.; Neuman, M. 1978: Cimetidine and other H2 receptor blockers Harefuah 95(7): 219-223
Pfleiderer, H.; Sturm, A. 1986: Beta-receptor blockers in pregnancy Deutsche Medizinische Wochenschrift 111(2): 76
Werning, C. 1980: Which beta receptor blockers should be used in hypertension? Fortschritte der Medizin 98(5): 157-160
Sabbah, Z.A.; Mansoor, A.; Kaul, U. 2013: Angiotensin receptor blockers - advantages of the new sartans Journal of the Association of Physicians of India 61(7): 464-470
Leschke, M.; Strouer, B.E. 1995: How selective are cardioselective beta-receptor blockers? Deutsche Medizinische Wochenschrift 120(1-2): 45-46
Fruhwald, F.M.; Kickenweiz, E.; Zweiker, R.; Klein, W. 2001: Angiotensin i receptor blockers for heart failure Wiener Medizinische Wochenschrift 151(7-8): 157-159
Oganov, R.G.; Nebieridze, D.V. 2002: Metabolic effects of angiotensin-Ii receptor blockers Kardiologiia 42(3): 35-39
Jira, T.; Breyer, C. 1993: The HPLC analysis of chiral beta-receptor blockers Die Pharmazie 48(11): 829-833
Ol'binskaia, L.I.; Morozov, I.A. 1996: Angiotensin-Ii receptor blockers in the treatment of arterial hypertension Eksperimental'naia i Klinicheskaia Farmakologiia 59(5): 76-80
Cheung, R. 2000: Living up to expectations? AT1-receptor blockers in clinical trials International Journal of Clinical Practice. Suppl 111: 25-28
Rettig, G. 1980: Beta receptor blockers in the therapy of coronary disease ZFA. Zeitschrift für Allgemeinmedizin 56(9): 600-605
Perakath, B.; Sitaram, V.; Khanduri, P.; Richard, J. 1999: Duodenal ulcer perforation: have H2 receptor blockers reduced mortality? Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 20(1): 53-54
Shevtsov, M.I. 2000: Angiotensin Ii receptor blockers - pilot experience and nephrology perspectives Terapevticheskii Arkhiv 72(6): 73-79
Franz, I.W.; Lohmann, F.W.; Rocker, I.; Kothari, P. 1979: Beta receptor blockers on ergometric work in hypertensive patients Indian Heart Journal 31(5): 259-262
Cervinka, P. 1998: Clinical use of glycoprotein IIb/IIIa receptor blockers in invasive cardiology Vnitrni Lekarstvi 44(7): 439-443
Dotzer, F.; Gromer, H. 1993: Indications spectrum for beta-1-selective adrenergic receptor blockers Fortschritte der Medizin 111(24): 382-384
Kumar, S.; Ram, C.V.S. 2007: Angiotensin receptor blockers: current status and future prospects Indian Heart Journal 59(6): 443-453